BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31672303)

  • 21. Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
    Calabrese A; Basile V; Puglisi S; Perotti P; Pia A; Saba L; Berchialla P; Porpiglia F; Veltri A; Volante M; Reimondo G; Berruti A; Terzolo M
    Eur J Endocrinol; 2019 Jun; 180(6):387-396. PubMed ID: 30991359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
    Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
    Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
    Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
    Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparate Practice Patterns and Survival Outcomes: The Impact of Centralization of Cancer Care for Adrenocortical Carcinoma in the United States.
    Stone BV; Tallman JE; Moses KA
    J Urol; 2021 Oct; 206(4):866-872. PubMed ID: 34032493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017.
    Gupta N; Rivera M; Novotny P; Rodriguez V; Bancos I; Lteif A
    Horm Res Paediatr; 2018; 90(1):8-18. PubMed ID: 29804118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis, treatment, and survival analysis of adrenocortical carcinomas: a multicentric study.
    Souteiro P; Donato S; Costa C; Pereira CA; Simões-Pereira J; Oliveira J; Belo S; Santos AP; Cardoso H; Leite V; Carvalho D; Torres I
    Hormones (Athens); 2020 Jun; 19(2):197-203. PubMed ID: 31823340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.
    Bednarski BK; Habra MA; Phan A; Milton DR; Wood C; Vauthey N; Evans DB; Katz MH; Ng CS; Perrier ND; Lee JE; Grubbs EG
    World J Surg; 2014 Jun; 38(6):1318-27. PubMed ID: 24615603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation therapies for adrenocortical carcinoma.
    Altieri B; Ronchi CL; Kroiss M; Fassnacht M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101434. PubMed ID: 32622829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal and newborn adrenocortical tumors.
    Isaacs H
    Fetal Pediatr Pathol; 2010 Jan; 29(2):99-107. PubMed ID: 20334485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
    Elfiky AA; Krishnan Nair HK
    Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-Target Approach to Metastatic Adrenal Cell Carcinoma.
    Wahab NA; Zainudin S; AbAziz A; Mustafa N; Sukor N; Kamaruddin NA
    Arch Iran Med; 2016 Sep; 19(9):671-3. PubMed ID: 27631184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenocortical carcinoma.
    Rodgers SE; Evans DB; Lee JE; Perrier ND
    Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical management of adrenocortical carcinoma.
    Fassnacht M; Allolio B
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):273-89. PubMed ID: 19500769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and management of adrenal cortical carcinoma.
    Fulmer BR
    Curr Urol Rep; 2007 Jan; 8(1):77-82. PubMed ID: 17239320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment of adrenal carcinoma.
    Gaujoux S; Weinandt M; Bonnet S; Reslinger V; Bertherat J; Dousset B
    J Visc Surg; 2017 Oct; 154(5):335-343. PubMed ID: 28754418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recent advances in the treatment of adrenocortical carcinomas].
    Ducry J; Berthold D; Pralong F
    Rev Med Suisse; 2012 Nov; 8(362):2181-4, 2186. PubMed ID: 23240320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [RESULTS OF DIAGNOSTICS AND TREATMENT OF ADRENOCORTICAL CANCER].
    Romashchenko PN; Maĭstrenko NA; Orlova RV; Babich AI
    Vestn Khir Im I I Grek; 2015; 174(3):29-39. PubMed ID: 26390585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adrenocortical carcinoma and its treatment].
    Tupikowski W; Bednarek-Tupikowska G; Florczak A
    Postepy Hig Med Dosw (Online); 2004 Feb; 58():27-36. PubMed ID: 15069374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of adrenocortical carcinoma accompanying secondary acute adrenal hypofunction postoperation.
    Kou K; Zhang H; Zhang C; Xie E; Chen Y; Wang G; Lv G
    World J Surg Oncol; 2018 Mar; 16(1):43. PubMed ID: 29506536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.